Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 84

1.

Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy.

Rieckert A, Trampisch US, Klaaßen-Mielke R, Drewelow E, Esmail A, Johansson T, Keller S, Kunnamo I, Löffler C, Mäkinen J, Piccoliori G, Vögele A, Sönnichsen A.

BMC Fam Pract. 2018 Jul 18;19(1):113. doi: 10.1186/s12875-018-0795-5.

2.
3.

The impact of a disease management programme for type 2 diabetes on health-related quality of life: multilevel analysis of a cluster-randomised controlled trial.

Panisch S, Johansson T, Flamm M, Winkler H, Weitgasser R, Sönnichsen AC.

Diabetol Metab Syndr. 2018 Apr 10;10:28. doi: 10.1186/s13098-018-0330-9. eCollection 2018.

4.

Correction to: Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults - a systematic review of reviews and the development of recommendations to reduce inappropriate prescribing.

Sommerauer C, Schlender L, Krause M, Weißbach S, Rieckert A, Martinez YV, Reeves D, Renom-Guiteras A, Kunnamo I, Sönnichsen A.

BMC Geriatr. 2018 Jan 16;18(1):12. doi: 10.1186/s12877-017-0663-5.

5.

Effectiveness and safety of dipeptidyl peptidase 4 inhibitors in the management of type 2 diabetes in older adults: a systematic review and development of recommendations to reduce inappropriate prescribing.

Schott G, Martinez YV, Ediriweera de Silva RE, Renom-Guiteras A, Vögele A, Reeves D, Kunnamo I, Marttila-Vaara M, Sönnichsen A.

BMC Geriatr. 2017 Oct 16;17(Suppl 1):226. doi: 10.1186/s12877-017-0571-8. Review.

6.

Effectiveness and safety of beta blockers in the management of hypertension in older adults: a systematic review to help reduce inappropriate prescribing.

Vögele A, Johansson T, Renom-Guiteras A, Reeves D, Rieckert A, Schlender L, Teichmann AL, Sönnichsen A, Martinez YV.

BMC Geriatr. 2017 Oct 16;17(Suppl 1):224. doi: 10.1186/s12877-017-0575-4. Review.

7.

Thiazides in the management of hypertension in older adults - a systematic review.

Sommerauer C, Kaushik N, Woodham A, Renom-Guiteras A, Martinez YV, Reeves D, Kunnamo I, Al Qur An T, Hübner S, Sönnichsen A.

BMC Geriatr. 2017 Oct 16;17(Suppl 1):228. doi: 10.1186/s12877-017-0576-3. Review.

8.

Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults - a systematic review of reviews and the development of recommendations to reduce inappropriate prescribing.

Sommerauer C, Schlender L, Krause M, Weißbach S, Rieckert A, Martinez YV, Reeves D, Renom-Guiteras A, Kunnamo I, Sönnichsen A.

BMC Geriatr. 2017 Oct 16;17(Suppl 1):223. doi: 10.1186/s12877-017-0573-6. Review. No abstract available. Erratum in: BMC Geriatr. 2018 Jan 16;18(1):12.

9.

Efficacy and safety of metformin in the management of type 2 diabetes mellitus in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing.

Schlender L, Martinez YV, Adeniji C, Reeves D, Faller B, Sommerauer C, Al Qur'an T, Woodham A, Kunnamo I, Sönnichsen A, Renom-Guiteras A.

BMC Geriatr. 2017 Oct 16;17(Suppl 1):227. doi: 10.1186/s12877-017-0574-5. Review.

10.

Effectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults - a systematic review.

Meinshausen M, Rieckert A, Renom-Guiteras A, Kröger M, Sommerauer C, Kunnamo I, Martinez YV, Esmail A, Sönnichsen A.

BMC Geriatr. 2017 Oct 16;17(Suppl 1):225. doi: 10.1186/s12877-017-0572-7. Review.

11.

A set of systematic reviews to help reduce inappropriate prescribing to older people: study protocol.

Martinez YV, Renom-Guiteras A, Reeves D, Erandie Ediriweera de Silva R, Esmail A, Kunnamo I, Rieckert A, Sommerauer C, Sönnichsen A.

BMC Geriatr. 2017 Oct 16;17(Suppl 1):231. doi: 10.1186/s12877-017-0570-9.

12.

Interventions to reduce inappropriate polypharmacy: Implications for research and practice.

Johansson T, Flamm M, Sönnichsen A, Schuler J.

Maturitas. 2017 Mar;97:66-68. doi: 10.1016/j.maturitas.2016.12.007. Epub 2016 Dec 26. No abstract available.

PMID:
28081964
13.

Reply to 'Endpoints in strategies to reduce polypharmacy'.

Johansson T, Flamm M, Sönnichsen A.

Br J Clin Pharmacol. 2017 Feb;83(2):434. doi: 10.1111/bcp.13125. Epub 2016 Oct 4. No abstract available.

14.

Cost analysis of a peer support programme for patients with type 2 diabetes: a secondary analysis of a controlled trial.

Johansson T, Keller S, Sönnichsen AC, Weitgasser R.

Eur J Public Health. 2017 Apr 1;27(2):256-261. doi: 10.1093/eurpub/ckw158.

PMID:
27694160
15.

Improving quality of care in general practices by self-audit, benchmarking and quality circles.

Mahlknecht A, Abuzahra ME, Piccoliori G, Enthaler N, Engl A, Sönnichsen A.

Wien Klin Wochenschr. 2016 Oct;128(19-20):706-718. Epub 2016 Sep 6.

16.

Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis.

Johansson T, Abuzahra ME, Keller S, Mann E, Faller B, Sommerauer C, Höck J, Löffler C, Köchling A, Schuler J, Flamm M, Sönnichsen A.

Br J Clin Pharmacol. 2016 Aug;82(2):532-48. doi: 10.1111/bcp.12959. Epub 2016 May 7. Review.

17.

Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome.

Sönnichsen A, Saulite I, Mangana J, Kerl K, Mehra T, Desislava I, Chang YT, Petrausch U, Schmid-Grendelmeier P, Hoetzenecker W, Cozzio A, Guenova E.

J Dermatolog Treat. 2016 Oct;27(5):436-8. doi: 10.3109/09546634.2015.1136048. Epub 2016 Feb 10.

PMID:
26864191
18.

Effectiveness of a Peer Support Programme versus Usual Care in Disease Management of Diabetes Mellitus Type 2 regarding Improvement of Metabolic Control: A Cluster-Randomised Controlled Trial.

Johansson T, Keller S, Winkler H, Ostermann T, Weitgasser R, Sönnichsen AC.

J Diabetes Res. 2016;2016:3248547. doi: 10.1155/2016/3248547. Epub 2015 Dec 20.

19.

Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.

Sönnichsen A, Trampisch US, Rieckert A, Piccoliori G, Vögele A, Flamm M, Johansson T, Esmail A, Reeves D, Löffler C, Höck J, Klaassen-Mielke R, Trampisch HJ, Kunnamo I.

Trials. 2016 Jan 29;17:57. doi: 10.1186/s13063-016-1177-8.

20.

Does COPD have a clinically relevant impact on hearing loss? A retrospective matched cohort study with selection of patients diagnosed with COPD.

Kamenski G, Bendova J, Fink W, Sönnichsen A, Spiegel W, Zehetmayer S.

BMJ Open. 2015 Nov 19;5(11):e008247. doi: 10.1136/bmjopen-2015-008247. Erratum in: BMJ Open. 2016 Dec 21;6(12 ):e008247corr1.

Supplemental Content

Loading ...
Support Center